NewLink Genetics (NLNK) Tops Q3 EPS by 11c

NewLink Genetics (NASDAQ: NLNK) reported Q3 EPS of ($0.55), $0.11 better than the analyst estimate of ($0.66).

Cash position:

NewLink Genetics ended the quarter on September 30, 2015, with cash, cash equivalents, and certificates of deposit totaling $200.4 million, compared to $202.8 million for the year ending December 31, 2014.

Guidance:

NewLink Genetics expects to have more than $160 million in cash and equivalents on December 31, 2015.

For earnings history and earnings-related data on NewLink Genetics (NLNK) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Movano (MOVE) Misses Q2 EPS by 195c